Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 77
Filter
1.
Ann Endocrinol (Paris) ; 80(2): 89-95, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30292450

ABSTRACT

OBJECTIVES: The tissue renin-angiotensin system (tRAS) plays a key role in the maintenance of cellular homeostasis but is also implicated in atherosclerosis. Thyroid hormone (TH) contributes, via genomic effects, to control of tRAS gene expression in the arterial wall and vascular smooth muscle cells (VSMCs). We investigated the specific functions of TH receptors-α and -ß (TRα and TRß) on tRAS gene expression in the aorta and VSMCs, and the potential protective effect of TRα against atherosclerosis. MATERIAL AND METHODS: Using aorta and cultured aortic VSMCs from TRα and TRß deficient mice, tRAS gene expression was analyzed by determining mRNA levels on real-time PCR. Gene regulation under cholesterol loading mimicking atherosclerosis conditions was also examined in VSMCs in vitro. RESULTS: TRα deletion significantly increased expression of angiotensinogen (AGT) and angiotensin II receptor type 1 subtype a (AT1Ra) at transcriptional level in aorta, a tissue with high TRα expression level. TRα activity thus seems to be required for maintenance of physiological levels of AGTand AT1Raexpression in the arterial wall. In addition, during cholesterol loading, TRα deletion significantly increased cholesterol content in VSMCs, with a weaker decrease in AGTexpression. CONCLUSION: TRα seems to have an inhibitory impact on AGTand AT1Raexpression, and loss of TRα function in TRα0/0 mice increases tRAS expression in the aortic wall. More importantly, TRα deletion significantly increases VSMC cholesterol content. Our results are consistent with a protective role of TRα against atherosclerosis.


Subject(s)
Arteries/metabolism , Atherosclerosis/genetics , Atherosclerosis/metabolism , Cholesterol/metabolism , Muscle, Smooth, Vascular/metabolism , Renin-Angiotensin System/genetics , Thyroid Hormone Receptors alpha/physiology , Animals , Arteries/pathology , Atherosclerosis/drug therapy , Atherosclerosis/pathology , Cells, Cultured , Down-Regulation/drug effects , Down-Regulation/genetics , Gene Expression Regulation/drug effects , Lipid Metabolism/drug effects , Lipid Metabolism/genetics , Male , Mice , Mice, Knockout , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/pathology , Renin-Angiotensin System/drug effects , Thyroid Hormone Receptors alpha/agonists , Thyroid Hormone Receptors alpha/genetics , Thyroid Hormones/pharmacology
2.
Oncotarget ; 9(57): 30979-30996, 2018 Jul 24.
Article in English | MEDLINE | ID: mdl-30123421

ABSTRACT

Our previous work demonstrated a key function of the thyroid hormone nuclear receptor TRα1, a T3-modulated transcription factor, in controlling intestinal development and homeostasis via the Wnt and Notch pathways. Importantly, increased expression of TRα1 in the intestinal epithelium in a mutated Apc genetic background (vil-TRα1/Apc+/1638N mice) accelerated tumorigenesis and contributed to a more aggressive tumor phenotype compared to that of the Apc mutants alone. Therefore, the aim of this study was to determine the relevance of this synergistic effect in human colorectal cancers and to gain insights into the mechanisms involved. We analyzed cohorts of patients by in silico and experimental approaches and observed increased TRα1 expression and a significant correlation between TRα1 levels and Wnt activity. TRα1 loss-of-function and gain-of-function in Caco2 cell lines not only confirmed that TRα1 levels control Wnt activity but also demonstrated the role of TRα1 in regulating cell proliferation and migration. Finally, upon investigation of the molecular mechanisms responsible for the Wnt-TRα1 association, we described the repression by TRα1 of several Wnt inhibitors, including Frzb, Sox17 and Wif1. In conclusion, our results underline an important functional interplay between the thyroid hormone nuclear receptor TRα1 and the canonical Wnt pathway in intestinal cancer initiation and progression. More importantly, we show for the first time that the expression of TRα1 is induced in human colorectal cancers.

3.
J Vasc Res ; 55(4): 224-234, 2018.
Article in English | MEDLINE | ID: mdl-30092589

ABSTRACT

Thyroid hormone (TH) regulates gene transcription by binding to TH receptors (TRs). TRs regulate the genes of lipid metabolism and the renin-angiotensin system (RAS). We examined the effect of TRα deletion in ApoE-/- mice (DKO mice) on the following: (i) the expression of genes controlling cholesterol metabolism and tissue (t)RAS in the liver and aorta and (ii) the expression of these genes and the regulation of cholesterol content in cultured vascular smooth muscle cells (VSMCs). TRα deletion in ApoE-/- mice led to the repression of genes involved in the synthesis and influx of cholesterol in the liver. However, TRα deletion in the arterial wall suppressed the expression of genes involved in the esterification and excretion of cholesterol and enhanced the expression of angiotensinogen (AGT). The VSMCs of the ApoE-/- and DKO mice increased their cholesterol content during cholesterol loading, but failed to increase the expression of ATP-binding cassette transporter A1 (ABCA1). T3 addition partially corrected these abnormalities in the cells of the ApoE-/- mice but not those of the DKO mice. In conclusion, TRα deletion in ApoE-/- mice slightly increases the expression of tRAS in the aorta and aggravates the dysregulation of cholesterol content in the VSMCs.


Subject(s)
Apolipoproteins E/deficiency , Cholesterol/metabolism , Muscle, Smooth, Vascular/metabolism , Renin-Angiotensin System/physiology , Thyroid Hormone Receptors alpha/deficiency , ATP Binding Cassette Transporter 1/genetics , Animals , Aorta/chemistry , Apolipoproteins E/genetics , Apolipoproteins E/physiology , Atherosclerosis/diagnostic imaging , Cells, Cultured , Cholesterol/administration & dosage , Cholesterol/genetics , Gene Expression , Hybridization, Genetic , Liver/chemistry , Male , Mice , Mice, Knockout , Muscle, Smooth, Vascular/chemistry , Muscle, Smooth, Vascular/cytology , RNA, Messenger , Thyroid Hormone Receptors alpha/genetics , Thyroid Hormone Receptors alpha/physiology , Triiodothyronine/pharmacology , Ultrasonography
4.
Methods Mol Biol ; 1801: 1-8, 2018.
Article in English | MEDLINE | ID: mdl-29892811

ABSTRACT

Thyroid hormone receptors (TRs) were cloned based on their homology with the retroviral oncogene v-ERBA. In Vertebrates two genes, THRA and THRB, encode respectively many isotypes and isoforms of receptors TRα and TRß, resulting from alternative splicing and/or internal transcription start sites. We present here a wide overview of this diversity and of their mechanisms of action as transcription regulators, as well as alternative actions through cytoplasmic signaling.


Subject(s)
Receptors, Thyroid Hormone/genetics , Receptors, Thyroid Hormone/metabolism , Animals , Gene Expression Regulation , Humans , Organ Specificity/genetics , Protein Isoforms , Receptors, Thyroid Hormone/chemistry , Research , Signal Transduction , Transcription, Genetic
5.
Cell Mol Life Sci ; 75(21): 3991-4005, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29804258

ABSTRACT

Most living organisms show circadian rhythms in physiology and behavior. These oscillations are generated by endogenous circadian clocks, present in virtually all cells where they control key biological processes. To study peripheral clocks in vivo, we developed an original model, the Rev-Luc mouse to follow noninvasively and longitudinally Rev-Luc oscillations in peripheral clocks using in vivo bioluminescence imaging. We found in vitro and in vivo a robust diurnal rhythm of Rev-Luc, mainly in liver, intestine, kidney and adipose tissues. We further confirmed in vivo that Rev-Luc peripheral tissues are food-entrainable oscillators, not affected by age or sex. These data strongly support the relevance of the Rev-Luc model for circadian studies, especially to investigate in vivo the establishment and the entrainment of the rhythm throughout ontogenesis. We then showed that Rev-Luc expression develops dynamically and gradually, both in amplitude and in phase, during fetal and postnatal development. We also demonstrate for the first time that the immature peripheral circadian system of offspring in utero is mainly entrained by maternal cues from feeding regimen. The prenatal entrainment will also differentially determine the Rev-Luc expression in pups before weaning underlining the importance of the maternal chrononutrition on the circadian system entrainment of the offspring.


Subject(s)
Animals, Newborn/physiology , Circadian Clocks/physiology , Circadian Rhythm/physiology , Feeding Behavior/physiology , Animals , Liver/physiology , Mice
6.
Proc Natl Acad Sci U S A ; 114(31): 8229-8234, 2017 08 01.
Article in English | MEDLINE | ID: mdl-28716910

ABSTRACT

Thyroid hormone receptors (TRs) are members of the nuclear hormone receptor superfamily that act as ligand-dependent transcription factors. Here we identified the ten-eleven translocation protein 3 (TET3) as a TR interacting protein increasing cell sensitivity to T3. The interaction between TET3 and TRs is independent of TET3 catalytic activity and specifically allows the stabilization of TRs on chromatin. We provide evidence that TET3 is required for TR stability, efficient binding of target genes, and transcriptional activation. Interestingly, the differential ability of different TRα1 mutants to interact with TET3 might explain their differential dominant activity in patients carrying TR germline mutations. So this study evidences a mode of action for TET3 as a nonclassical coregulator of TRs, modulating its stability and access to chromatin, rather than its intrinsic transcriptional activity. This regulatory function might be more general toward nuclear receptors. Indeed, TET3 interacts with different members of the superfamily and also enhances their association to chromatin.


Subject(s)
Chromatin/metabolism , Dioxygenases/metabolism , Thyroid Hormone Receptors alpha/metabolism , Catalytic Domain , Chromatin/genetics , Dioxygenases/genetics , Gene Expression Regulation , HEK293 Cells , Humans , Immunoprecipitation , Mutation , Nitriles/pharmacology , Protein Interaction Domains and Motifs , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Thiazoles/pharmacology , Thyroid Hormone Receptors alpha/genetics , Thyroid Hormone Receptors beta/genetics , Thyroid Hormone Receptors beta/metabolism , Transcription, Genetic , Ubiquitination
7.
Cell Rep ; 19(11): 2202-2209, 2017 06 13.
Article in English | MEDLINE | ID: mdl-28614708

ABSTRACT

The obesity epidemic is a significant global health issue. Improved understanding of the mechanisms that regulate appetite and body weight will provide the rationale for the design of anti-obesity therapies. Thyroid hormones play a key role in metabolic homeostasis through their interaction with thyroid hormone receptors (TRs), which function as ligand-inducible transcription factors. The TR-beta isoform (TRß) is expressed in the ventromedial hypothalamus (VMH), a brain area important for control of energy homeostasis. Here, we report that selective knockdown of TRß in the VMH of adult mice results in severe obesity due to hyperphagia and reduced energy expenditure. The observed increase in body weight is of a similar magnitude to murine models of the most extreme forms of monogenic obesity. These data identify TRß in the VMH as a major physiological regulator of food intake and energy homeostasis.


Subject(s)
Body Weight/genetics , Eating/genetics , Thyroid Hormone Receptors beta/metabolism , Ventromedial Hypothalamic Nucleus/metabolism , Animals , Body Weight/physiology , Male , Mice
8.
Endocrinology ; 158(7): 2052-2057, 2017 07 01.
Article in English | MEDLINE | ID: mdl-28472304

ABSTRACT

Current literature makes a distinction between two pathways for thyroid hormone signaling: genomic and nongenomic. However, this classification is a source of confusion. We propose a clarification in the nomenclature that may help to avoid unproductive controversies and favor progress in this field of research. Four types of thyroid hormone signaling are defined, and the experimental criteria for classification are discussed.


Subject(s)
Terminology as Topic , Thyroid Hormones/physiology , Animals , DNA/metabolism , Humans , Receptors, Thyroid Hormone/metabolism , Signal Transduction , Thyroid Hormones/classification , Transcription Factors/metabolism
9.
J Biol Chem ; 292(11): 4533-4543, 2017 03 17.
Article in English | MEDLINE | ID: mdl-28115522

ABSTRACT

UHRF2 has been implicated as a novel regulator for both DNA methylation (5mC) and hydroxymethylation (5hmC), but its physiological function and role in DNA methylation/hydroxymethylation are unknown. Here we show that in mice, UHRF2 is more abundantly expressed in the brain and a few other tissues. Uhrf2 knock-out mice are viable and fertile and exhibit no gross defect. Although there is no significant change of DNA methylation, the Uhrf2 null mice exhibit a reduction of 5hmC in the brain, including the cortex and hippocampus. Furthermore, the Uhrf2 null mice exhibit a partial impairment in spatial memory acquisition and retention. Consistent with the phenotype, gene expression profiling uncovers a role for UHRF2 in regulating neuron-related gene expression. Finally, we provide evidence that UHRF2 binds 5hmC in cells but does not appear to affect the TET1 enzymatic activity. Together, our study supports UHRF2 as a bona fide 5hmC reader and further demonstrates a role for 5hmC in neuronal function.


Subject(s)
5-Methylcytosine/analogs & derivatives , Brain/physiology , DNA Methylation , Spatial Learning , Ubiquitin-Protein Ligases/metabolism , 5-Methylcytosine/analysis , 5-Methylcytosine/metabolism , Animals , Brain Chemistry , Cell Line , Female , Humans , Locomotion , Male , Memory , Mice , Mice, Knockout , Ubiquitin-Protein Ligases/analysis , Ubiquitin-Protein Ligases/genetics
10.
PLoS One ; 11(5): e0156445, 2016.
Article in English | MEDLINE | ID: mdl-27227989

ABSTRACT

MicroRNA-135a (miR-135a) down-modulates parameters of cancer progression and its expression is decreased in metastatic breast cancers (as compared to non-metastatic tumors) as well as in prostate tumors relative to normal tissue. These expression and activity patterns are opposite to those of the Estrogen-Related Receptor α (ERRα), an orphan member of the nuclear receptor family. Indeed high expression of ERRα correlates with poor prognosis in breast and prostate cancers, and the receptor promotes various traits of cancer aggressiveness including cell invasion. Here we show that miR-135a down-regulates the expression of ERRα through specific sequences of its 3'UTR. As a consequence miR-135a also reduces the expression of downstream targets of ERRα. miR-135a also decreases cell invasive potential in an ERRα-dependent manner. Our results suggest that the decreased expression of miR-135a in metastatic tumors leads to elevated ERRα expression, resulting in increased cell invasion capacities.


Subject(s)
Breast Neoplasms/metabolism , Gene Expression Regulation, Neoplastic , MicroRNAs/metabolism , Neoplasm Proteins/biosynthesis , Prostatic Neoplasms/metabolism , RNA, Neoplasm/metabolism , Receptors, Estrogen/biosynthesis , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Cell Line, Tumor , Female , Humans , Male , MicroRNAs/genetics , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasm Proteins/genetics , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , RNA, Neoplasm/genetics , Receptors, Estrogen/genetics , ERRalpha Estrogen-Related Receptor
11.
Endocrine ; 50(3): 689-97, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26041374

ABSTRACT

Resistance to thyroid hormone (RTH) is a rare genetic disease caused by reduced tissue sensitivity to thyroid hormone. The hallmark of RTH is elevated serum levels of thyroid hormone with unsuppressed thyrotropin (TSH). However, the most common form of RTH results from minor defects in the ligand-binding domain or hinge domain of the TRß gene, resulting in impaired T3-induced transcriptional activity, often showing mild presentation. Early diagnosis can be challenging. The objective of the current study was to characterize this specific group of RTH patients. This was a retrospective study. Patients diagnosed as RTH with TRß mutations were enrolled in a single institute between 2004 and 2014. A total of 14 patients were diagnosed as RTH with mutation in THß gene. The median age at diagnosis was 22.5 (IQR: 13.25-32.75). Goiter was the most common clinical finding. TSH was significantly elevated after TRH injection (median peak was 21.83 µIU/l, IQR: 13.59-31.48), 9.2-fold compared to the basal level. We found 10 mutations in TRß gene, all located in the last four exons, and including one novel mutation, H271D. In vitro study found that H271D mutation reduced TR affinity to T3. Four patients with intact thyroid were diagnosed after 16 years old, defined as late manifestation. Compared to those diagnosed before 10 years old, patients with late manifestation presented with normal growth and mental development. Interestingly, three of them carried R438H mutation. We identified a novel p.H271D mutation in TRß associated with RTH. Endocrinologists should be alert that RTH is frequently found in euthyroid patients with mild symptoms and often leads to misleading diagnosis as well as inappropriate treatment.


Subject(s)
Genes, erbA , Thyroid Hormone Resistance Syndrome/genetics , Adolescent , Adult , Female , Genotype , Humans , Male , Mutation , Retrospective Studies , Thyroid Hormone Resistance Syndrome/diagnosis , Young Adult
12.
Chembiochem ; 15(10): 1413-7, 2014 Jul 07.
Article in English | MEDLINE | ID: mdl-24943922

ABSTRACT

A three-component probe harnesses the extraordinary properties of a solid-state fluorophore for the detection of living cells exhibiting a particular peptidase activity. The off-on mode by which the probe operates, the bright fluorescence of the resulting precipitate, and the rapid response allow an exceptional signal-to-background ratio during microscopic imaging. A tertiary carbamate link between the spacer and phenolic fluorophore is at the heart of the probe's long-term stability. The degree of chlorination of the probe determines its response time and thus its suitability for live-cell analysis. Our probe also allows highly resolved localization of peptidase activity during gel analysis or on agar. In comparison, probes releasing soluble fluorophores demonstrate complete diffusion of the fluorescent signal. These results demonstrate the probe's potential for diverse biomedical applications, including high-fidelity flow cytometry and sensitive colony assays.


Subject(s)
Fluorescent Dyes/analysis , Leucyl Aminopeptidase/analysis , Leucyl Aminopeptidase/metabolism , Cell Survival , Fluorescence , Fluorescent Dyes/metabolism , HeLa Cells , Humans , Microscopy, Fluorescence , Spectrometry, Fluorescence
14.
Endocrinology ; 155(7): 2735-45, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24797634

ABSTRACT

Hypothyroidism is associated with an increased occurrence of atherosclerosis, suggesting some protective role for thyroid hormones (THs). Hypercholesterolemia is one of the major risk factor to develop this disease. Here, we show that the well-known TH cholesterol lowering effect was dependent on TH nuclear receptor (TR)ß liver activity. But most importantly, TRα was also shown to contribute of slowing down atherosclerosis progression via an independent mechanism. Introduction of TRα(0/0) deletion in the ApoE(-/-) background accelerated the appearance of plaques. Earlier cholesterol accumulation was detected in aorta macrophages, likely due to impaired cholesterol efflux. The IL-1ß inflammatory cytokine was elevated in serum and macrophages in correlation with an activation of the AKT/nuclear factor κB pathway in these cells. Inhibition of AKT prevented inflammation and restored normal cholesterol efflux. Similar low-grade inflammation was identified in TRα(0/0) male mice. Thus, the mere absence of TRα is associated with elevated levels of cytokines likely responsible for cholesterol accumulation and atherosclerosis. This TRα protective activity should be relevant for other inflammatory pathologies.


Subject(s)
Atherosclerosis/genetics , Inflammation/genetics , Thyroid Hormone Receptors alpha/genetics , Animals , Aorta/metabolism , Aorta/pathology , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Atherosclerosis/blood , Atherosclerosis/metabolism , Blotting, Western , Bone Marrow Transplantation/methods , Cell Nucleus/metabolism , Cells, Cultured , Cholesterol/blood , Cholesterol/metabolism , Inflammation/blood , Inflammation/metabolism , Interleukin-1beta/blood , Interleukin-1beta/metabolism , Macrophages/metabolism , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , NF-kappa B/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Thyroid Hormone Receptors alpha/deficiency , Thyroid Hormones/blood , Thyroid Hormones/metabolism
16.
Org Biomol Chem ; 12(22): 3641-8, 2014 Jun 14.
Article in English | MEDLINE | ID: mdl-24756609

ABSTRACT

A family of fluorescent push-pull pH-responsive probes based on 2-dicyanomethylidene-3-cyano-4,5,5-trimethyl-2,5-dihydrofuran as a strong electron acceptor group is described. Small structural variations allow obtaining pK(a) ranging from 4.8 to 8.6, underlining the role of the substituent in modulating the acidic properties. Remarkable changes in the optical properties (in particular the fluorescence intensity ratios) were observed as a function of pH. The most interesting probes with pK(a) close to neutrality were used for ratiometric imaging of intracellular pH.


Subject(s)
Fluorescent Dyes/metabolism , Intracellular Space/metabolism , Molecular Probe Techniques , HeLa Cells , Humans , Hydrogen-Ion Concentration , Microscopy, Confocal , Spectrometry, Fluorescence
17.
PLoS One ; 9(3): e92039, 2014.
Article in English | MEDLINE | ID: mdl-24643087

ABSTRACT

The protein of retroviral origin ENS-1/ERNI plays a major role during neural plate development in chick embryos by controlling the activity of the epigenetic regulator HP1γ, but its function in the earlier developmental stages is still unknown. ENS-1/ERNI promoter activity is down-regulated upon differentiation but the resulting protein expression has never been examined. In this study, we present the results obtained with custom-made antibodies to gain further insights into ENS-1 protein expression in Chicken embryonic stem cells (CES) and during their differentiation. First, we show that ENS-1 controls the activity of HP1γ in CES and we examined the context of its interaction with HP1γ. By combining immunofluorescence and western blot analysis we show that ENS-1 is localized in the cytoplasm and in the nucleus, in agreement with its role on gene's promoter activity. During differentiation, ENS-1 decreases in the cytoplasm but not in the nucleus. More precisely, three distinct forms of the ENS-1 protein co-exist in the nucleus and are differently regulated during differentiation, revealing a new level of control of the protein ENS-1. In silico analysis of the Ens-1 gene copies and the sequence of their corresponding proteins indicate that this pattern is compatible with at least three potential regulation mechanisms, each accounting only partially. The results obtained with the anti-ENS-1 antibodies presented here reveal that the regulation of ENS-1 expression in CES is more complex than expected, providing new tracks to explore the integration of ENS-1 in CES cells regulatory networks.


Subject(s)
Avian Proteins/genetics , Embryonic Stem Cells/metabolism , Fetal Proteins/genetics , Gene Expression Regulation, Developmental , Amino Acid Sequence , Animals , Antibodies, Monoclonal, Murine-Derived/biosynthesis , Antibodies, Monoclonal, Murine-Derived/chemistry , Avian Proteins/metabolism , Cell Differentiation , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Chick Embryo , Chromosomal Proteins, Non-Histone/genetics , Chromosomal Proteins, Non-Histone/metabolism , Cytoplasm/metabolism , Cytoplasm/ultrastructure , Embryonic Development , Embryonic Stem Cells/ultrastructure , Epigenesis, Genetic , Fetal Proteins/metabolism , Gene Regulatory Networks , Mice , Molecular Sequence Data , Neural Plate/embryology , Neural Plate/metabolism , Neural Plate/ultrastructure , Promoter Regions, Genetic , Protein Isoforms/genetics , Protein Isoforms/metabolism
19.
Endocrinology ; 155(2): 635-46, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24265449

ABSTRACT

Thyroid epithelial cells, or thyrocytes, express functional thyroid hormone receptors but no precise role has yet been assigned to either TRα or TRß in the thyroid gland. In this study, we analyzed the impact of inactivating the TRß gene in the thyroid of mice. First, we generated a mouse line named Thyr-Cre, expressing the Cre recombinase under the control of the thyroglobulin gene promoter, which led to a complete recombination of floxed genes in thyrocytes. Thyr-Cre mice were then crossed with TRß floxed mice (TRß(flox/flox)) to obtain a thyrocyte-selective deletion of TRß. Thyr-TRß(-/-) mice were characterized by a decrease in the size and functional activity of the thyroid gland. These alterations were associated with a decrease in plasma TSH concentration. Surprisingly, Thyr-TRß(-/-) displayed elevated serum T(4) and rT(3) concentrations with no significant change in serum T(3) levels. Their intrathyroidal free T(4) and rT(3) contents were also elevated, whereas the ratio of serum T(4) to thyroid free T(4) was decreased by comparison with wild-type littermates. Also, within the thyroid, deiodinases D1 and D2 were reduced as well as the expression levels of genes encoding monocarboxylate transporters (Mct8 and Mct10). Such a decrease in intrathyroidal deiodination of T(4) and in the expression of genes encoding thyroid hormone transporters may contribute to the primary overproduction of T(4) observed in Thyr-TRß(-/-) mice. In conclusion, these data show that the control of thyroid hormone production involves not only TRß-dependent mechanisms acting at the level of hypothalamus and pituitary but also TRß-dependent mechanisms acting at the thyroid level.


Subject(s)
Thyroid Gland/metabolism , Thyroid Hormone Receptors beta/genetics , Thyroid Hormones/biosynthesis , Thyrotropin/blood , Animals , Gene Expression Regulation , Iodide Peroxidase/genetics , Iodide Peroxidase/metabolism , Membrane Transport Proteins/genetics , Membrane Transport Proteins/metabolism , Mice , Monocarboxylic Acid Transporters , Promoter Regions, Genetic , Symporters , Thyroid Gland/cytology , Thyroid Hormone Receptors beta/metabolism , Iodothyronine Deiodinase Type II
20.
PLoS One ; 8(6): e66278, 2013.
Article in English | MEDLINE | ID: mdl-23840433

ABSTRACT

BACKGROUND: Several data favor androgen receptor implication in prostate cancer initiation through the induction of several gene activation programs. The aim of the study is to identify potential biomarkers for early diagnosis of prostate cancer (PCa) among androgen-regulated genes (ARG) and to evaluate comparative expression of these genes in normal prostate and normal prostate-related androgen-sensitive tissues that do not (or rarely) give rise to cancer. METHODS: ARG were selected in non-neoplastic adult human prostatic epithelial RWPE-1 cells stably expressing an exogenous human androgen receptor, using RNA-microarrays and validation by qRT-PCR. Expression of 48 preselected genes was quantified in tissue samples (seminal vesicles, prostate transitional zones and prostate cancers, benign prostatic hypertrophy obtained from surgical specimens) using TaqMan® low-density arrays. The diagnostic performances of these potential biomarkers were compared to that of genes known to be associated with PCa (i.e. PCA3 and DLX1). RESULTS AND DISCUSSION: By crossing expression studies in 26 matched PCa and normal prostate transitional zone samples, and 35 matched seminal vesicle and PCa samples, 14 genes were identified. Similarly, 9 genes were overexpressed in 15 benign prostatic hypertrophy samples, as compared to PCa samples. Overall, we selected 8 genes of interest to evaluate their diagnostic performances in comparison with that of PCA3 and DLX1. Among them, 3 genes: CRYAB, KCNMA1 and SDPR, were overexpressed in all 3 reference non-cancerous tissues. The areas under ROC curves of these genes reached those of PCA3 (0.91) and DLX1 (0.94). CONCLUSIONS: We identified ARG with reduced expression in PCa and with significant diagnostic values for discriminating between cancerous and non-cancerous prostatic tissues, similar that of PCA3. Given their expression pattern, they could be considered as potentially protective against prostate cancer. Moreover, they could be complementary to known genes overexpressed in PCa and included along with them in multiplex diagnostic tools.


Subject(s)
Biomarkers, Tumor/metabolism , Carrier Proteins/metabolism , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/metabolism , Prostatic Neoplasms/diagnosis , alpha-Crystallin B Chain/metabolism , Antigens, Neoplasm/genetics , Antigens, Neoplasm/metabolism , Biomarkers, Tumor/genetics , Carrier Proteins/genetics , Cell Line, Tumor , Early Detection of Cancer , Gene Expression , Gene Expression Regulation, Neoplastic , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/genetics , Male , Metribolone/pharmacology , Organ Specificity , Phosphate-Binding Proteins , Prostate/metabolism , Prostatic Neoplasms/genetics , Prostatic Neoplasms/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , ROC Curve , Real-Time Polymerase Chain Reaction , Seminal Vesicles/metabolism , Testosterone Congeners/pharmacology , Transcription Factors/genetics , Transcription Factors/metabolism , alpha-Crystallin B Chain/genetics
SELECTION OF CITATIONS
SEARCH DETAIL